<DOC>
	<DOCNO>NCT00129857</DOCNO>
	<brief_summary>Each year large number patient hospitalize Shock Trauma Centers severe head injury . Bleeding swell patient ' brain may cause compression vital structure , disability death . Sometimes surgery need . Unfortunately , investigator medication treat bad effect head trauma . Part brain damage due toxic chemical ( include one call glutamate ) release damaged nerve . Dexanabinol may prevent bad effect glutamate brain may protect brain uncontrollable swell death .</brief_summary>
	<brief_title>Dexanabinol Severe Traumatic Brain Injury</brief_title>
	<detailed_description>Dexanabinol synthetic , non-psychotropic cannabinoid derivative dextro-configuration compatible activation cannabinoid receptor brain . It combine ability block NMDA receptor neuroinflammatory cascade molecule . Dexanabinol scavenge free radical , protects neuron toxicity free radical generator inhibit lipopolysaccharide-induced production prostaglandin E2 , NO TNF-a macrophages culture .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>HU 211</mesh_term>
	<mesh_term>Dronabinol</mesh_term>
	<criteria>Traumatic head injury within last 6 hour Glasgow Coma Motor score 2 5 ; severity require intracranial pressure ( ICP ) monitoring Brain compute tomography ( CT ) show intracranial parenchymal abnormality hemodynamically stable An informed consent Penetrating head injury Spinal cord injury Coma due pure epidural hematoma initial Glasgow Coma Scale ( GCS ) = &gt; 12 Previous major cerebral damage Concomitant severe condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2004</verification_date>
</DOC>